Miracor Medical

Miracor Medical

Belgium - Awans
Medical Devices

Focus: Devices for Heart Disease

Miracor Medical is a life sciences company focused on Devices for Heart Disease.

CardiovascularMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Clinical Trials (1)
NCT04566289Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance
N/A
PiCSO
STEMI
N/A
Clinical Trials (1)
NCT03625869Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction
N/A
Clinical Trials (1)
NCT01493037PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention
N/A
Clinical Trials (1)
NCT03473015Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion
N/A
Clinical Trials (1)
NCT04958421A Study to Evaluate Safety and Feasibility of PiCSO Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction.
N/A
Clinical Trials (1)
NCT05497011A Study to Evaluate the Safety and Efficacy of PiCSO in Anterior STEMI Patients
N/A
Clinical Trials (1)
NCT02197325PiCSO in ACS Study
N/A
PiCSO Impulse System
Anterior Myocardial Infarction
N/A
Clinical Trials (1)
NCT05644925Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute Microvascular Resistance by Continuous Thermodilution in ST-segment Elevation Myocardial Infarction (STEMI) Patients: PiCSO-STEMI TRIAL
N/A
Phase 2
Clinical Trials (1)
NCT01308125Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention
Phase 2
Clinical Trials (1)
NCT04032925The Pressure-controlled Intermittent Coronary Sinus Occlusion on VentrIcular PERformance Study
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 10 clinical trials

Visa Sponsorship

H-1B Petitions (FY2023)
0
Approved
1
Denied
0%
Rate

Source: USCIS H-1B Employer Data Hub